Get the Stockscreener App
1.25
1.57%
-0.02
After Hours:
1.28
0.03
+2.40%
Soligenix Inc stock is traded at $1.25, with a volume of 108.40K.
It is down -1.57% in the last 24 hours and down -8.09% over the past month.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
See More
Previous Close:
$1.27
Open:
$1.29
24h Volume:
108.40K
Relative Volume:
0.13
Market Cap:
$4.08M
Revenue:
$960.60K
Net Income/Loss:
$-7.10M
P/E Ratio:
-0.1653
EPS:
-7.56
Net Cash Flow:
$-8.00M
1W Performance:
-11.97%
1M Performance:
-8.09%
6M Performance:
-45.89%
1Y Performance:
-71.06%
1-Day Range:
$1.21
$1.305
1-Week Range:
$1.18
$1.4499
52-Week Range:
$1.09
$5.40
Soligenix Inc Stock (SNGX) Company Profile
Name
Soligenix Inc
Sector
Industry
Phone
609-538-8200
Address
29 EMMONS DRIVE, PRINCETON
Compare SNGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNGX
Soligenix Inc
|
1.25 | 4.15M | 960.60K | -7.10M | -8.00M | -7.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Soligenix Inc Stock (SNGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-20 | Downgrade | Dawson James | Buy → Neutral |
| Jan-31-18 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Aug-14-17 | Reiterated | Maxim Group | Buy |
| Jul-17-17 | Initiated | H.C. Wainwright | Buy |
Soligenix Inc Stock (SNGX) Latest News
What momentum shifts mean for Soligenix Inc.ROI Focused Setup Screener With Exit Markers - Newser
Can technical indicators confirm Soligenix Inc.’s reversalTechnical Confirmation System with Signal Alerts - Newser
What institutional flow reveals about Soligenix Inc.Long-Term Trend Tracking and Signal Summary - Newser
Why Soligenix Inc. stock attracts strong analyst attentionMulti-Year Investment Performance Summary Report - Newser
Multi factor analysis applied to Soligenix Inc.ROI Focused Watchlist with Trade Confidence - Newser
What makes Soligenix Inc. stock price move sharplyHistorical Stock Summary and ROI Review - Newser
Long term hold vs stop loss in Soligenix Inc.ROI Focused Setup Screener With Exit Markers - Newser
Soligenix Inc. Stock Support and Resistance Levels You Should KnowAI Based High Gain Watchlist Scanner Shared - metal.it
Real time social sentiment graph for Soligenix Inc.High Yield Watchlist with Filtered Picks - Newser
Order Flow Trends Show Accumulation in Soligenix Inc.Weekly Stock Opportunity Radar Scanner Activated - metal.it
How did Soligenix's revenue and expenses trend in Q4 2024? - AInvest
Published on: 2025-07-29 03:42:31 - metal.it
Why is Soligenix Inc. stock attracting strong analyst attentionDaily Trading Signals That Work - jammulinksnews.com
What is the dividend policy of Soligenix Inc. stockCapitalize on market momentum for profits - jammulinksnews.com
What is Soligenix Inc. company’s growth strategyAchieve breakthrough investment performance - jammulinksnews.com
How volatile is Soligenix Inc. stock compared to the marketTake advantage of unprecedented market momentum - jammulinksnews.com
What is the risk reward ratio of investing in Soligenix Inc. stockIdentify safe investments with exceptional yields - jammulinksnews.com
Top Risks to Consider Before Buying Soligenix Inc. StockStable Stocks With High Yield - Newser
What catalysts could drive Soligenix Inc. stock higher in 2025Capitalize on market trends with confidence - jammulinksnews.com
How Soligenix Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser
Soligenix Inc. Advances Treatment for Behçet’s Disease with SGX945 - citybuzz -
What analysts say about Soligenix Inc. stockSky-high return potential - PrintWeekIndia
Soligenix Inc. Stock Analysis and ForecastFree Capital Allocation Plans - PrintWeekIndia
Soligenix (NASDAQ: SNGX) Pioneering Oral Mucositis Treatment with Novel Therapeutic - The Globe and Mail
Soligenix (NASDAQ: SNGX) Pioneering Oral Mucositis Treatment With Novel Therapeutic - Barchart.com
How Soligenix Inc. stock reacts to Fed policy changesPhenomenal wealth increase - jammulinksnews.com
Is Soligenix Inc. stock a good hedge against inflationAccelerated capital growth - jammulinksnews.com
What drives Soligenix Inc. stock priceExtraordinary performance - PrintWeekIndia
Will Soligenix Inc. stock split in the near futureOutstanding stock performance - jammulinksnews.com
Non-Hodgkin’s Lymphoma Market Forecast to Surge with Growing Adoption of Targeted and Cell-Based Therapies | DelveInsight - GlobeNewswire Inc.
Is Soligenix Inc. a good long term investmentPhenomenal trading returns - jammulinksnews.com
Soligenix Inc Stock (SNGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):